Biofarm, a leading Romanian drug manufacturer, plans to invest 47 million lei in upgrading its production plant on Logofătul Tăutu Street and developing a new research and development center. The project aims to modernize equipment in order to improve the efficiency of manufacturing processes and better respond to market demands. CEO Cătălin Vicol emphasizes that this initiative is part of Biofarm's strategy to increase its presence on international markets.
Sources
Producătorul de medicamente Biofarm are în plan modernizarea primei fabrici din Bucureşti şi un centru nou de cercetare. Bugetul de investiţii al Biofarm în 2025 este de 47 mil. lei (aproape 10 mil. euro), în creştere faţă de anul anterior, cand a fost de 31 mil. lei
Producătorul de medicamente Biofarm are în plan modernizarea primei fabrici din Bucureşti şi un centru nou de cercetare
Latest News
14:25
Smuggled cigarettes hidden in the carriages of the Kyiv–Chisinau–Bucharest train. Six people, including a CFR employee, under investigation
14:22
South Korea’s government tightens exam controls after an AI cheating scandal
14:16
Intel, sued by investors after its share price fell
14:16
A 45-year-old man from Tighina, detained at Chișinău’s “Eugen Doga” Airport upon returning from Russia and placed in pretrial detention for 30 days
14:06
Romania calls for EU–NATO coordination after three commercial vessels were hit by drones near Sulina
See more news